Department of Pharmacy, University of Naples Federico II, via Domenico Montesano 49, 80131 Naples, Italy.
Samnium Medical Soc. Cooperative, 82100 Benevento, Italy.
Phytomedicine. 2021 Jan;80:153368. doi: 10.1016/j.phymed.2020.153368. Epub 2020 Oct 8.
The most common symptoms of mild upper respiratory tract infections (URTIs) are sore throat, muffled dysphonia, and swelling and redness of the throat, which result from the inflammation process following acute bacterial or viral infection.
HYPOTHESIS/PURPOSE: As propolis is a natural resinous substance traditionally used to maintain oral cavity and upper respiratory tract health due to its antimicrobial and anti-inflammatory properties, the aim of this study is to evaluate the efficacy of an oral spray based on poplar-type propolis extract with a known and standardized polyphenol content, on the remission of the symptoms associated with mild uncomplicated URTIs.
A monocentric, randomized, double-blind, placebo-controlled clinical trial was performed.
This study was conducted in 122 healthy adults who had perceived mild upper respiratory tract infections. Participants, randomly assigned to receive either propolis oral spray (N = 58) or placebo (N = 64), underwent four visits (baseline = t0, after 3 days = t1 and after 5 days = t2 and after a follow-up of 15 days = t3) in an outpatient setting. Propolis oral spray total polyphenol content was 15 mg/ml. The dosage was 2-4 sprays three times/day (corresponding to 12-24 mg of polyphenols/day), for five days. The duration of the study was 8 weeks.
After 3 days of treatment, 83% of subjects treated with propolis oral spray had remission of symptoms, while 72% of subjects in the placebo group had at least one remaining symptom. After five days, all subjects had recovered from all symptoms. This means that resolution from mild uncomplicated URTIs took place two days earlier, instead of taking place in five days as recorded in the control group. There was no relationship between the ingestion of propolis oral spray or placebo and adverse reactions.
Propolis oral spray can be used to improve both bacterial and viral uncomplicated URTI symptoms in a smaller number of days without the use of pharmacological treatment, leading to a prompt symptom resolution.
轻度上呼吸道感染(URTI)最常见的症状是喉咙痛、声音嘶哑、喉咙肿胀和发红,这些症状是由急性细菌或病毒感染后的炎症过程引起的。
假设/目的:由于蜂胶具有抗菌和抗炎特性,因此是一种传统上用于维持口腔和上呼吸道健康的天然树脂物质,本研究旨在评估一种基于白杨型蜂胶提取物的口腔喷雾剂的疗效,该提取物具有已知且标准化的多酚含量,用于缓解轻度单纯性 URTI 相关症状。
进行了一项单中心、随机、双盲、安慰剂对照的临床试验。
这项研究纳入了 122 名自觉患有轻度上呼吸道感染的健康成年人。参与者随机分配接受蜂胶口腔喷雾剂(N=58)或安慰剂(N=64),在门诊环境中进行了四次就诊(基线=t0,治疗后 3 天=t1,治疗后 5 天=t2,治疗后 15 天=t3)。蜂胶口腔喷雾剂的总多酚含量为 15mg/ml。剂量为每天 2-4 次喷雾,每次 3 次(相当于每天 12-24mg 多酚),连续 5 天。研究持续 8 周。
治疗 3 天后,83%接受蜂胶口腔喷雾剂治疗的受试者症状缓解,而安慰剂组 72%的受试者至少仍有一个症状。治疗 5 天后,所有受试者均已从所有症状中恢复。这意味着,与对照组中记录的需要 5 天才能痊愈相比,轻度单纯性 URTI 的痊愈时间提前了两天。接受蜂胶口腔喷雾剂或安慰剂与不良反应之间没有关系。
蜂胶口腔喷雾剂可用于在较短的天数内改善细菌和病毒引起的单纯性 URTI 症状,而无需使用药物治疗,从而迅速缓解症状。